Randomised, Double-Blind, Placebo-Controlled, Phase IIa Study in Healthy Volunteers to Evaluate the Protective Efficacy and Safety of CR8020 in an Influenza Challenge Model

Trial Profile

Randomised, Double-Blind, Placebo-Controlled, Phase IIa Study in Healthy Volunteers to Evaluate the Protective Efficacy and Safety of CR8020 in an Influenza Challenge Model

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs CR 8020 (Primary)
  • Indications Influenza A virus infections
  • Focus Pharmacokinetics
  • Sponsors Crucell
  • Most Recent Events

    • 03 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Oct 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2013-002185-39).
    • 12 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top